Sponsorship Statement: This continuing medical education activity is joint sponsored by 
and 
.
Support Statement: This activity is supported by an educational grant from 
.
Target Audience: This activity has been designed to meet the educational needs of cardiologists who see patients with both cardiometabolic issues and ACS; internists and other primary care physicians who help manage ACS patients and their metabolic problems in follow-up; and endocrinologists and diabetologists who manage patients with type 2 diabetes and/or other drivers of cardiovascular risk.
Learning Objectives: At the conclusion of this activity participants should be able to:
- Examine the relationship between diabetes and acute coronary syndromes (ACS).
- Discuss current clinical data related to insulin management of hyperglycemia in the ACS setting.
- Evaluate current and emerging pharmacologic options for cardiovascular risk reduction and explore their therapeutic potential in the post-ACS patient with prediabetes or diabetes.
Course Chair/Moderator:
Jorge Plutzky, MD (Planning Committee)
Director, The Vascular Disease Prevention Program
Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
Faculty:
Richard W. Nesto, MD
Chair, Department of Cardiovascular Medicine
Chief Medical Officer
Lahey Clinic Medical Center
Burlington, Massachusetts
Professor of Medicine
Tufts University School of Medicine
Boston, Massachusetts
External Reviewer:
Ronald Codario, MD
Accreditation:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Vindico Medical Education and Consensus Medical Communications . Vindico Medical Education is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, July 16, 2012 to July 15, 2013.
How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, watch and listen to the presentations, complete the posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 out of 3 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Planning Committee and Faculty members report the following relationship(s):
Jorge Plutzky, MD (Planning Committee)
Consultant: Abbott, Amylin Pharmaceuticals, Bristol-Myers Squibb, Daiichi Sankyo, GlaxoSmithKline, Merck, Novo Nordisk, Orexigen, Pfizer, Genentech, Takeda and Vivus
Richard W. Nesto, MD
Consulting Fees: Genentech and Merck
External Reviewer reports the following relationship(s):
Ronald Codario, MD
No relevant financial relationships to disclose.
Vindico Medical Education and Consensus Medical Communications staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2012 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education and Consensus Medical Communications continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education and Consensus Medical Communications. Neither Vindico Medical Education, Consensus Medical Communications, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.